We are proud to announce that Ergomed’s Site Start-Up (SSU) Team has been named finalists for the prestigious PharmaTimes International Clinical Researcher of the Year 2025 in the Start-Up Team category.
Meet Ergomed’s Study Start-Up Team
Stefanie Sausenthaler, Senior Manager, Study Start up, shared, “Successful study start-up is the foundation of impactful clinical research, and our Study Start Up team is committed to making this process as seamless and efficient as possible. Through collaboration, expertise, and a shared drive for excellence, we work towards accelerating site activations, enabling patient enrolment to begin without delays—all while ensuring full compliance with regulatory requirements, ICH/GCP guidelines, and the study protocol. Our collective experience and dedication create a strong, solution-focused environment where teamwork is key to overcoming challenges with the ultimate goal to improve patient care. Study start-up is more than just a phase in a clinical trial—it is the critical first step in making a real difference. As a dedicated Study Start-Up team, we streamline processes, foster collaboration, and remove barriers to expedite the launch of clinical trials. With precision, efficiency, and unwavering commitment, we turn possibilities into progress—driving innovation that improves lives.”